China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...

Benzinga licenses actionable, market-moving stock news content that is both original and aggregated. Benzinga’s editorial team cuts through the noise to provide unbiased content for your users’ ...